Publicacions en què col·labora amb José-Juan Pereyra-Rodríguez (20)

2024

  1. Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)

    Journal of the European Academy of Dermatology and Venereology

2023

  1. Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus

    Acta Dermato-Venereologica, Vol. 103

  2. Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis From the Patient's Perspective: A Systematic Review

    Dermatitis

  3. Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

    Journal of Investigational Allergology and Clinical Immunology

  4. Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results

    Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997

  5. Upadacitinib for moderate to severe atopic dermatitis

    Immunotherapy, Vol. 15, Núm. 11, pp. 799-808

2022

  1. Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)

    Life

  2. Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review

    Life, Vol. 12, Núm. 8

  3. Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort-Real Life: Fifty-Two-Week Follow-up Results

    Dermatitis : contact, atopic, occupational, drug, Vol. 33, Núm. 6, pp. S124-S127

  4. Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning

    International journal of environmental research and public health, Vol. 19, Núm. 17

2021

  1. 104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain

    Anais Brasileiros de Dermatologia, Vol. 96, Núm. 6, pp. 787-790

  2. Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study

    British Journal of Dermatology

  3. Short-term effectiveness and safety of biologics and small molecule drugs for moderate to severe atopic dermatitis: A systematic review and network meta-analysis

    Life, Vol. 11, Núm. 9

2020

  1. A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 3, pp. 222-228

  2. Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain

    Dermatologic Therapy, Vol. 33, Núm. 6

  3. The Safety of Dupilumab in Clinical Practice: 52 Weeks of Experience at 5 Referral Hospitals in Andalusia

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 699-700

2019

  1. Dupilumab: short-term effectiveness and security in real clinical practice – A retrospective multicentric study

    Journal of the European Academy of Dermatology and Venereology

  2. Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series

    Dermatologic Therapy, Vol. 32, Núm. 4

  3. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series

    British Journal of Dermatology

2018

  1. Adult atopic dermatitis: From physiopathology to therapeutics (II)

    Piel